PedAM
Pediatric Disease Annotations & Medicines
| Disease | diarrhea |
| Phenotype | C0027947|neutropenia |
| Sentences | 8 |
| PubMedID- 22870042 | Among toxicities, the differences in the risks of neutropenia with hospitalization, diarrhea, nausea, and fatigue had the most impact on preferences; the risk differences of myalgia, stomatitis, and hand-foot syndrome had the least. |
| PubMedID- 23429739 | Severe neutropenia occurred in 47% of patients, and severe diarrhea occurred in 47% of patients. |
| PubMedID- 22382883 | The maximal tolerated dose (mtd) was reached at 300 mg/day where 2 patients out of 6 experienced a dose limiting toxicity (febrile neutropenia with diarrhea). |
| PubMedID- 26266093 | Nine days after chemotherapy, the patient presented a febrile neutropenia with worsening diarrhea, intermittent nausea, vomiting, and acute abdominal pain. |
| PubMedID- 23055694 | Important side effects include neutropenia, elevation of liver enzymes, diarrhea, infections, and elevation of blood pressure. |
| PubMedID- 20308874 | Grades 3 and 4 hematological toxicities were neutropenia in 44% of patients, grade 2-3 diarrhea in 14% of patients, and grade 2 neuropathy in 12 patients. |
| PubMedID- 22253528 | Grade 3/4 toxicities included neutropenia in 6–46% of patients, diarrhea in 4–33% of patients, skin toxicity in 6–24% of patients, and anaphylaxis to cetuximab in <5% of patients. |
| PubMedID- 23476759 | A total of 412 citations were identified for two cancer-treatment-related symptoms of diarrhea and fever with neutropenia (see figure 1). |
Page: 1